Sg Americas Securities, LLC I Mab Transaction History

Sg Americas Securities, LLC

$30.5 Billion
Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in I Mab stock. As of the latest transaction made, Sg Americas Securities, LLC holds 822,041 shares of IMAB stock, worth $748,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

822,041

Previous 475,862 72.75%

Holding current value

$748,057

Previous $404,000 67.57%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$0.8 - $1.1 $276,943 - $380,796	346,179 Added 72.75%	822,041 $677,000
Q4 2024 Jan 17, 2025	BUY	$0.85 - $1.6 $404,482 - $761,379	475,862 New	475,862 $404,000
Q4 2022 Feb 02, 2023	BUY	$3.22 - $4.86 $2,051 - $3,095	637 Added 4.52%	14,723 $62,000
Q3 2022 Oct 31, 2022	SELL	$4.01 - $12.34 $54,323 - $167,169	-13,547 Reduced 49.02%	14,086 $56,000
Q2 2022 Jul 29, 2022	SELL	$8.27 - $18.43 $130,384 - $290,567	-15,766 Reduced 36.33%	27,633 $312,000
Q1 2022 Apr 29, 2022	SELL	$12.54 - $46.93 $1.64 Million - $6.14 Million	-130,826 Reduced 75.09%	43,399 $705,000
Q4 2021 Feb 07, 2022	BUY	$45.28 - $74.5 $6.71 Million - $11 Million	148,109 Added 567.12%	174,225 $8.26 Million
Q3 2021 Nov 01, 2021	BUY	$57.18 - $84.43 $2,172 - $3,208	38 Added 0.15%	26,116 $1.89 Million
Q2 2021 Aug 12, 2021	BUY	$47.86 - $83.95 $929,919 - $1.63 Million	19,430 Added 292.27%	26,078 $2.19 Million
Q1 2021 May 13, 2021	BUY	$44.38 - $63.97 $49,173 - $70,878	1,108 Added 20.0%	6,648 $322,000
Q4 2020 Feb 04, 2021	SELL	$32.94 - $47.15 $25,232 - $36,116	-766 Reduced 12.15%	5,540 $261,000
Q3 2020 Nov 09, 2020	SELL	$27.46 - $47.03 $360,137 - $616,798	-13,115 Reduced 67.53%	6,306 $297,000
Q2 2020 Jul 20, 2020	SELL	$13.0 - $31.0 $90,844 - $216,628	-6,988 Reduced 26.46%	19,421 $582,000
Q1 2020 Apr 30, 2020	BUY	$10.63 - $15.37 $280,727 - $405,906	26,409 New	26,409 $343,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

13.8M

Call Options Held

20K

Put Options Held

13.3K

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $75.6M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC I Mab Transaction History